June 11, 2022The Journal of Headache and Pain429 citationsOpen Access

European Headache Federation guideline on the use of monoclonal antibodies targeting the calcitonin gene related peptide pathway for migraine prevention – 2022 update

Key points are not available for this paper at this time.

Monoclonal antibodies targeting the CGRP pathway are recommended for migraine prevention as they are effective and safe also in the long-term.

问 AI

Bookmark

View Full Paper

问 AI

Bookmark

View Full Paper

Cite This Study